A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd

Trial Profile

A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs PF 4457845 (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Nov 2015 Status changed from suspended to discontinued, as reported by ClinicalTrials.gov.
    • 19 Jun 2015 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
    • 04 May 2015 Status changed from suspended to active, no longer recruiting as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top